Cardiac Dimensions announces key management changes

Mr Cornelison comes to Cardiac Dimensions from Arrow International, a medical device company that manufactures critical care and cardiac assist devices. While there, he held numerous senior management positions within the regulatory affairs and quality assurance arena.

Most recently, Mr Cornelison was vice president of regulatory affairs for the Asia international business. Mr Cornelison will be responsible for all worldwide regulatory filings, and will coordinate the company’s US and international product approval efforts.

Mr Mehta joins Cardiac Dimensions from Northstar Neuroscience, where he served as vice president of clinical affairs. During this time he led clinical studies in both the US and Europe, and worked closely with the FDA on the company’s key clinical strategies. Mr Mehta will take the lead in establishing Cardiac Dimensions’s pivotal trial strategy and execution for the Carillon Mitral Contour System.

Rick Stewart, Cardiac Dimensions’s president and CEO, said: “We are very excited to have both of these quality individuals on board and I know Paul and Nawzer look forward to working with our entire team to help advance our innovative therapy to the next level and ultimately address a huge unmet clinical need.”